title: Antiglucocorticoid strategies in hypercortisolemic states.
abstract: Major depressive illness is frequently associated with cortisol hypersecretion. The pathophysiologic significance of this is unknown, although it is possible that hypercortisolemia exacerbates or perpetuates depressive symptoms. In both depression and Cushing's syndrome, certain depressive symptoms are correlated with cortisol levels and, in the latter condition, therapeutic lowering of cortisol levels is associated with remission of psychiatric symptomatology. We review the behavioral effects of anticortisolemic drug administration in Cushing's syndrome and major depression. Preliminary data from small-scale studies suggest that ratings of depressive symptoms in hypercortisolemic major depression may be lowered by such interventions. Such results, if confirmed in larger scale, double-blind studies, might help clarify the role of endocrinologic disturbance in psychiatric symptomatology and might lead to the development of a novel class of antidepressant agent for hypercortisolemic depressed patients.
authors: Department of Psychiatry, University of California San Francisco Medical Center 94143-0984.
authors: O M
authors: OM
authors: Wolkowitz
authors: V I
authors: VI
authors: Reus
authors: F
authors: F
authors: Manfredi
authors: J
authors: J
authors: Ingbar
authors: L
authors: L
authors: Brizendine
mesh_terms: D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy*; D005938:Glucocorticoids / Q000037:antagonists & inhibitors*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*
chemical_list: D005938:Glucocorticoids; D006854:Hydrocortisone